GFRA1 and osteosarcoma: After treating osteosarcoma cells with cisplatin, a widely used anticancer drug, it induces the overexpression of GFRα1, which promotes autophagy to lead to enhanced osteosarcoma cell survival via the SRC-AMPK signaling axis.